A LinkedIn post from Cooler Heads highlights recent legislative developments in California affecting coverage for scalp cooling treatments. According to the post, G…
After a breast cancer diagnosis, Melinda Fletcher became the first patient at Ascension Saint Agnes to try scalp-cooling therapy.
10th Annual Bioelectronic Medicine Forum An Investment and Management Conference for Entrepreneurs and Executives April 13, 2027 This tenth annual meeting marks a decade as the premier management and investment conference for the bioelectronic medicine industry, a field that has moved from scientific promise to commercial reality since the first Forum convened. Attendees will have
Dignity Health and the Comprehensive Blood & Cancer Center highlighted an advancement in local cancer treatment Tuesday morning.
Changing the narrative: Cold capping technology helps cancer patients keep their hair Read More »
The new law will expand coverage of FDA-cleared scalp-cooling technology for some cancer patients starting Jan. 1.
A new California law may help more cancer patients keep their hair Read More »
Koya will hold private meetings at the BofA Healthcare Trailblazers Private Company Conference
Koya Medical to Attend BofA Healthcare Trailblazers Private Company Conference Read More »
Buena Vista Regional Healthcare Foundation’s AWARE fund purchased scalp cooling therapy equipment for patients undergoing chemotherapy, potentially reducing hair loss while providing a sense of …
AWARE fund brings scalp cooling therapy to BVRMC patients Read More »
Overview Agenda Speakers Sponsors Presenting Companies Brochure Venue New York Academy of Medicine, New York, NY, April 14, 2026 Tentative Agenda, All Times EDT 8:15-8:30 Welcome and Introductions 8:30-9:00 Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor, Neurotech Reports BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including
Agenda – 2026 Bioelectronic Medicine Forum Read More »
TEAYS was a prospective, multicenter, randomized, crossover clinical trial conducted at nine U.S. sites in 71 patients with confirmed lower-extremity lymphedema. The study directly compared Dayspring with an advanced pneumatic compression device across limb-volume reduction, disease-specific quality of life, treatment adherence and patient preference.
